Table 1. Demographic and Clinical Characteristics of Patients with WDEIA and AGS.
Characteristics | Patients with WDEIA (n=45) | Patients with AGS (n=39) | ||
---|---|---|---|---|
Age, yr | 44.5±18.0 | 65.5±9.5 | ||
Male | 29 (64.4) | 19 (48.7) | ||
History of anaphylaxis | 37 (82.2) | 23 (59.0) | ||
Duration | (n=44) | (n=36) | ||
1 month | 9 (20.5) | 8 (22.2) | ||
1–12 months | 11 (25.0) | 10 (27.8) | ||
1–5 years | 14 (31.8) | 7 (19.4) | ||
>5 years | 10 (22.7) | 11 (30.6) | ||
Positivity of specific IgE tests | ||||
ImmunoCAP assay | (n=45) | (n=39) | ||
Omega-5 gliadin specific IgE | 45 (100)* | - | ||
Gluten-specific IgE | 39 (87.7) | - | ||
Wheat-specific IgE | 25 (55.6) | - | ||
α-gal specific IgE | - | 39 (100) | ||
Pork-specific IgE | - | 32 (85.7) | ||
Beef-specific IgE | - | 37 (96.4) | ||
MAST | (n=15) | (n=17) | ||
Wheat-specific IgE | 5 (33.3) | - | ||
Pork-specific IgE | - | 0 (0) | ||
Beef-specific IgE | - | 0 (0) |
WDEIA, wheat-dependent exercise-induced anaphylaxis; AGS, α-gal syndrome; MAST, multiple allergen simultaneous test; IgE, immunoglobulin E.
Data are presented as mean±standard deviation or n (%).
*Positive results were defined as ≥class 1 in each tests.